Communiqués Rafarma Pharmaceuticals, Inc.

Actions

RAFA

US75062C1009

Marché Fermé - OTC Markets Autres places de cotation 18:14:48 15/07/2024			Varia. 5j.	Varia. 1 janv.
0,061 ^USD	-15,28%		-12,86%	-76,66%

03/07

Rafarma Pharmaceuticals établit une coentreprise industrielle dans le parc technologique de Busan avec Woods Medical Care, Inc.

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea	04/07	AQ
Rafarma pharmaceutical updates: creation of a joint research and production enterprise in Busan (South Korea) between Rafarma and the Korean pharmaceutical company Woods Medical Care	03/07	AQ
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifesciences (Pvt) Ltd and El Salvador University	11/12	AQ
Rafarma Pharmaceutical news update	30/11	AQ
Rafarma Pharmaceuticals : RAFA Financials Q2	15/08/22	PU
Rafarma Pharmaceuticals strengthens its position in Central Asia	29/04/22	AQ
Rafarma’s Slavich Noya Technology Division Expands Printing Production	07/02/22	AQ
RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research	21/12/21	AQ
RAFA To Add Major Component to the Tashkent Pharma Park	17/12/21	AQ
Explosive Growth Launches Kraspharma Into REMEDIUM TOP-5	19/11/21	AQ
Rafarma Enters Negotiations With Leading Global Producer of Precious Metals to Localize Production of Platinum-Based Cancer Drugs	19/08/21	GL
Letter to Shareholders from the Chairman of the Board Ilya Shpurov	10/08/21	GL
Rafarma Signs Trilateral Investment Agreement Officially Launching Tashkent Pharmaceutical Plant Build	30/07/21	GL
Rafarma’s Global Pharmaceutical Strategy At A Glance	18/05/21	GL
Rafarma To Expand Proton Therapy Centers	07/05/21	GL
Rafarma and Haifa Technopark Enter Talks for Joint Venture	30/04/21	GL
Rafarma Embarks on Aggressive Global Partnerships Plan	04/03/21	GL
Rafarma Secures Joint Venture Agreement with the Pharmaceutical Industry Development Agency of Uzbekistan	29/01/21	GL
Rafarma Merger Company Bebig Approved For Production And Sale Of Yttrium-90 For Treatment Of Inoperable Liver Cancer	09/12/20	GL
Rafarma Inks Joint Venture Agreement with Vaccines Lab SDN BHD of Malaysia	01/12/20	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Rafarma Pharmaceuticals, Inc.

Actions

RAFA

US75062C1009

Communiqués

Filtres